| |
 |
CURRENT NEWS ( VIEW NEWS ARCHIVES)
Click here for Triathlon Medical Ventures related videos on YouTube
March 3, 2010
Endocyte Announces DSMB Supports Continuation of Phase 2 PRECEDENT Study
February 3, 2010
Triathlon Medical Ventures and Affinity Capital Announce Collaboration in the Formation of the Minnesota Life Sciences Seed Fund
January 2010
MIST Therapy® The Haiti Health Care Crisis
November 10, 2009
BioVex completes $70 million financing to conclude pivotal study with its pioneering cancer treatment, OncoVEXGM-CSF (External Link)
November 3, 2009
Tolera Therapeutics Files IND Application for TOL101, Appoints O’Toole to Lead Clinical Operations
October 22, 2009
Endocyte Unveils Data on Ovarian Cancer Treatment (External Link)
October 15, 2009
Endocyte Announces Close of $26 Million Equity Financing
September 15, 2009
Akebia Announces Initiation of Phase 1 Clinical Study of AKB-6548
September 15, 2009
BioVEX Agrees SPA with the FDA for a Pivotal Phase III Study with OncoVEXGM-CSF in Head and Neck Cancer (External Link)
August 31, 2009
Akebia Appoints Victor Dzau, M.D. to Board of Directors
August 26, 2009
Endocyte Announces Achievement of Second Milestone in Collaboration with
Bristol-Myers Squibb
July 28, 2009
Akebia Completes $16M Expansion of Series A Financing
July 1, 2009
Celleration Appoints Mark T. Wagner President and Chief Executive Officer (External Link)
April 7, 2009
Tolera Therapeutics Granted Orphan Drug Designation for Organ Transplant Rejection Drug
BACK TO TOP
|
| |
|
 |
|
|
